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Introduction
The data on incidence and causes of anaphylaxis during
anesthesia in children are lacking. Latex, neuromuscular
blocking agents (NMBAs) and antibiotics are most
frequently described causes but more data including
assessment of cross reactivity of drugs and information
of subsequent anaesthesia would be useful.
Methods
We prospectively included 13 children (8 girls, aged 2 to
13 years) that were referred to our department for inves-
tigation the cause of systemic allergic reaction during
anaesthesia between 2010-13. Diagnostic procedure
included detailed history, skin prick and intradermal test-
ing, detection of specific IgE antibodies (to suxametonium,
morphin, latex, beta-lactams (BL), chlorhexidine) and
provocation tests (nonsteroidal anti-inflammatory drugs,
benzodiazepines and latex). We performed also basophil
activation tests (BAT) with BL, NMBAs, midazolam,
propofol and glucocorticoids. Stimulation index (SI) >2
was considered positive.
Results
Five children presented with anaphylaxis and eight with
urticaria/angioedema. Seven of them had reaction during
their first anaesthesia. Seven children had positive testing
results to one group of drugs or one substance (two
to NMBAs, two to BL, one to glucocorticoids, one to
opioids and one to latex). Three children presented with
positive testing results to more than one group of drugs
(one to NMBAs, opioids and benzodiazepines, one to
NMBA, benzodiazepines and isopropyl alcohol and one
to benzodiazepines and garamicin). Two children had
dermographism. In one child parents did not want to
start diagnosing procedure. Cross- reactivity within the
group of medication was found in eleven children
(among NMBA, BL, glucocorticoids, benzodiazepines and
opioids). BAT for NMBA was positive in three of four
children allergic to NMBAs, in both children allergic to
BL, in one child allergic to glucocorticoids and in one of
three children allergic to midazolam. Four children had
uncomplicated following anaesthesia, one girl vomited
during the next anaesthesia.
Conclusions
Causes of anaphylaxis during anaesthesia in children are
diverse. Multiple positive testing results complicate further
potential anaesthesia. BAT can be a useful additional
diagnosing method in immediate hypersensitivity reactions
occurring during anaesthesia.
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